These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 11721128)
1. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary. Bencsik K; Rajda C; Füvesi J; Klivényi P; Járdánházy T; Török M; Vécsei L Eur Neurol; 2001; 46(4):206-9. PubMed ID: 11721128 [TBL] [Abstract][Full Text] [Related]
2. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis. Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311 [TBL] [Abstract][Full Text] [Related]
3. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of clinical characteristics for 'benign' multiple sclerosis. Ramsaransing GS; De Keyser J Eur J Neurol; 2007 Aug; 14(8):885-9. PubMed ID: 17662009 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of multiple sclerosis in Csongrád County, Hungary. Zsiros V; Fricska-Nagy Z; Füvesi J; Kincses ZT; Langane E; Paulik E; Vécsei L; Bencsik K Acta Neurol Scand; 2014 Nov; 130(5):277-82. PubMed ID: 24611546 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy Data in a Turkish Multiple Sclerosis Population. Altintas A; Najar B; Gozubatik-Celik G; Menku SF Eur Neurol; 2015; 74(5-6):296-302. PubMed ID: 26656283 [TBL] [Abstract][Full Text] [Related]
8. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802 [TBL] [Abstract][Full Text] [Related]
18. An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population. Gray OM; Abdeen H; McDonnell GV; Patterson CC; Graham CA; Hawkins SA Mult Scler; 2009 Mar; 15(3):299-303. PubMed ID: 19244395 [TBL] [Abstract][Full Text] [Related]
19. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living. Kamm CP; Heldner MR; Vanbellingen T; Mattle HP; Müri R; Bohlhalter S Arch Phys Med Rehabil; 2012 Jun; 93(6):1081-5. PubMed ID: 22464095 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of follow-up and disease course]. Roullet E Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1121-3. PubMed ID: 11787343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]